Malnutrition Often Seen in Patients Treated for IBD
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 12, 2024 -- Some patients seen in an inflammatory bowel disease (IBD) clinic screen positive for malnutrition, according to a research letter published online Nov. 20 in Gastro Hep Advances.
Aaron C. Viser, from the University of North Carolina at Chapel Hill, and colleagues used data from a multidisciplinary IBD clinic (June 7 to July 19, 2022) of 237 adult patients with confirmed Crohn disease or ulcerative colitis (UC) presenting for routine, in-person clinical care screened for malnutrition using the Malnutrition Screening Tool (MST).
The researchers found that the screening took two to three minutes per patient to administer, with 14 percent screening positive for malnutrition (Crohn disease: 15 percent; UC: 12 percent). Among IBD patients who screened positive for malnutrition, being a new consult; having a normal body mass index, active disease, and history of smoking; and taking corticosteroid or aminosalicylate medications were more common. The prevalence of a positive screen was higher (28 percent) among patients with active disease and lower (8 percent) among patients in remission. When adjusting for age and sex, IBD patients with active disease were more likely to screen positive for malnutrition versus those in remission (odds ratio [OR], 4.6; 95 percent confidence interval [CI], 2.1 to 10.2). A positive screen was also more likely among former smokers (OR, 2.4; 95 percent CI, 1.0 to 5.7) and current smokers (OR, 2.3; 95 percent CI, 0.4 to 12.3) compared with nonsmokers.
"The validated three-question MST could be easily implemented in routine clinical care in an IBD clinic with the aim to provide same-day dietitian support for patients at risk for malnutrition," the authors write.
One author disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
WEDNESDAY, July 17, 2024 -- For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for...
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne
WEDNESDAY, July 10, 2024 -- Adherence to a Mediterranean diet incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces skin lesions and improves quality of...
Long-Term Healthy Dietary Patterns Linked to Healthy Aging
FRIDAY, July 5, 2024 -- Higher long-term adherence to healthy dietary patterns is associated with an increased likelihood of healthy aging, according to a study presented at...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.